SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2012 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (202)2/29/2012 6:58:46 PM
From: Biotech Jim   of 513
 
<Aren't picks retroactive? I had VVUS last year.....>

I had REGN last year... But at least I still hold some of it in my personal account. Thought that REGN had run too far last year. Oh well... , my bad.

VVUS is not a guarantee, but I have at least some bets placed. The strong secondary at $22.50 and the fact that the stock is up after hours today, above that price, continues to be bullish for the stock. BUT, there is at least one impediment in the way. The FDA still has the big decision as all of us know. It was smart for VVUS to have this secondary now. If they would not have done it, management would have qualified for bonehead of the year award. Small price for insurance and for leverage in any possible buyout discussions. (My bet is that JNJ will buy out VVUS at some point - with several provisos pending.)

Us biotech investors should remember that rallies like these for the entire sector do not last forever, and we all should be taking some profits along the way. Unfortunately (or fortunately, perhaps) we are not able to do this in the contest.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext